1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.
about
Niacin Alternatives for Dyslipidemia: Fool's Gold or Gold Mine? Part II: Novel Niacin MimeticsRNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells.Oxidative stress: Biomarkers and novel therapeutic pathways.New strategies for Alzheimer's disease and cognitive impairment.Diabetes mellitus: channeling care through cellular discoveryMetabonomic investigation of single and multiple strain Trypanosoma brucei brucei infections.Liquid chromatography-mass spectrometry method for the analysis of 1,4-dimethylpyridinium in rat plasma--application to pharmacokinetic studies.N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis.Targeted, LCMS-based Metabolomics for Quantitative Measurement of NAD(+) Metabolites.Novel avenues of drug discovery and biomarkers for diabetes mellitus.Nanomechanical sensing of the endothelial cell response to anti-inflammatory action of 1-methylnicotinamide chloride.Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.Nonclinical evaluation of novel cationically modified polysaccharide antidotes for unfractionated heparinEffects of 1-Methylnicotinamide (MNA) on Exercise Capacity and Endothelial Response in Diabetic Mice.Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization.The effects of 1,4-dimethylpyridine in metastatic prostate cancer in miceNicotinamide N-oxidation by CYP2E1 in human liver microsomes.Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.The Wnt signaling pathway: aging gracefully as a protectionist?Erythropoietin: elucidating new cellular targets that broaden therapeutic strategiesErythropoietin and oxidative stress.1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasisDietary fat overcomes the protective activity of thrombospondin-1 signaling in the Apc(Min/+) model of colon cancer.Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.Copper oxide nanoparticle toxicity profiling using untargeted metabolomicsThe vitamin nicotinamide: translating nutrition into clinical care.Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophagesBrain-derived neurotrophic factor plasma levels and premature cognitive impairment/dementia in type 2 diabetesMetabolomic Analysis of Liver Tissue from the VX2 Rabbit Model of Secondary Liver TumorsFunctional and Biochemical Endothelial Profiling In Vivo in a Murine Model of Endothelial Dysfunction; Comparison of Effects of 1-Methylnicotinamide and Angiotensin-converting Enzyme Inhibitor.Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme.Neuroprotective effects of nicotinamide N-methyltransferase and its metabolite 1-methylnicotinamide.Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression.The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors.Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients.A metabolomic approach to clarifying the effect of AST-120 on 5/6 nephrectomized rats by capillary electrophoresis with mass spectrometry (CE-MS).Bioappearance and pharmacokinetics of bioactives upon coffee consumption.Nicotinamide N-methyltransferase in non-small cell lung cancer: promising results for targeted anti-cancer therapy.Effects of breaking up prolonged sitting on skeletal muscle gene expression.
P2860
Q26765137-C9193113-3ABF-4E11-9654-EC3D12EAADF7Q31131231-93F1A934-B496-4ED6-ADC5-542888EB7857Q33682262-1F4373EE-D861-4BD0-94B6-108CB3FACAA0Q33717008-DE632B72-B158-42C9-BEC4-B442F510167CQ33749358-981050BF-560E-4920-B2A5-60F979975972Q33787802-F70CDE38-6104-4FC3-B052-C5FCD3619B66Q34253226-D24A99E2-DE14-421E-83B2-DA28E9872E98Q34260260-4F76EC6F-74FA-4BC8-946D-10B4DC8C4FF7Q34413049-808755B3-3967-4215-8796-6CEE68B4CB74Q34552287-AC44D850-926F-41D8-8457-3D4651B58067Q34942278-9A0A576E-4E15-4E1A-A995-0A680B483075Q35157985-626343EE-BA7D-4E1A-AEF8-667CDBDDFDEEQ35185880-1578AAAA-1330-41FC-BCAB-2B2984BF9EC7Q35675886-B179CFE2-93A9-447A-AC7C-5F9B508586D1Q35929036-30B2CB90-21B1-49C9-B592-500359181DD7Q36300102-B9F3E288-E165-4E3C-AE87-8125FEC55AD1Q36642348-E437BE56-28CC-434D-BB66-B5084327A0A3Q36727444-9B7BEAC8-DED9-44D2-BADE-287EF4867F30Q36728844-BBE69521-32C5-4CC9-9CAF-4C872F953FBDQ36740470-A7AFC58E-2D45-4AC9-8E73-B0ED99E1E51DQ36944477-3B13F891-6F5E-4524-A8D4-BD88E923A2B7Q37093441-B6EE4A15-CB67-4953-9B2D-A1ECFF161D7AQ37096252-2BFBFE02-3AAB-420F-8C87-95268605C41FQ37223938-A9D95A0F-BEA9-4978-AFB0-EED6A4875B2AQ37243903-BDA13F11-6CD6-49E3-8A37-76D7838189C6Q37374047-7FEBE0C9-096E-4A19-BF3E-988CDF045557Q37376937-388ED9C4-BC3A-49E5-A869-44C872739EA0Q37397862-673234AD-D835-485A-A4E3-6C792F36956EQ37501264-E778BD29-F272-43BB-A694-0D4EBB3EE613Q37645012-1C705B0E-E81E-498E-9EF3-E285E592BF79Q37742934-7303102D-310F-4331-935B-3AF3BEB7C97BQ38746034-C5E4C252-5ED9-4D2D-AD7E-E04F205BFCA4Q39123712-7F6DB68F-4151-4203-9A63-0DF73AD922CEQ39558109-A0F7F7E2-37B0-41EE-B3DC-391DDDE994AEQ39586047-DA9947BA-622A-492B-AD69-91C9FF586F30Q41102388-2C5F2E04-E305-432D-A6D7-A47D19458A90Q42366987-E75972CE-6B3E-4011-80C8-01FB79B52911Q43412099-5F5F652E-50F8-43ED-B4E6-D27440043141Q44201011-53CA5B7D-D286-4E6F-8D7A-C2F953B27FCEQ45844498-594F29F2-E65C-4C2E-820F-33E276AF03E9
P2860
1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
1-Methylnicotinamide (MNA), a ...... genase-2/prostacyclin pathway.
@ast
1-Methylnicotinamide (MNA), a ...... genase-2/prostacyclin pathway.
@en
type
label
1-Methylnicotinamide (MNA), a ...... genase-2/prostacyclin pathway.
@ast
1-Methylnicotinamide (MNA), a ...... genase-2/prostacyclin pathway.
@en
prefLabel
1-Methylnicotinamide (MNA), a ...... genase-2/prostacyclin pathway.
@ast
1-Methylnicotinamide (MNA), a ...... genase-2/prostacyclin pathway.
@en
P2093
P2860
P50
P356
P1476
1-Methylnicotinamide (MNA), a ...... ygenase-2/prostacyclin pathway
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0707383
P407
P577
2007-07-16T00:00:00Z